A detailed history of Huntington National Bank transactions in Albireo Pharma, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1 shares of ALBO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$0.0 - $44.95 $0 - $36,139
-804 Reduced 99.88%
1 $0
Q4 2022

Feb 09, 2023

SELL
$18.01 - $23.78 $1,440 - $1,902
-80 Reduced 9.04%
805 $17,000
Q3 2022

Nov 07, 2022

BUY
$16.32 - $26.37 $3,361 - $5,432
206 Added 30.34%
885 $17,000
Q2 2022

Aug 09, 2022

BUY
$18.54 - $37.29 $10,641 - $21,404
574 Added 546.67%
679 $13,000
Q1 2022

May 10, 2022

SELL
$23.94 - $33.74 $47 - $67
-2 Reduced 1.87%
105 $3,000
Q4 2021

Jan 21, 2022

BUY
$21.19 - $31.29 $2,267 - $3,348
107 New
107 $2,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.